[Screening and management of coronary artery disease in diabetic patients]

Sondos Kraiem1, Chedly Abassi, Nizar Annabi

  • 1Service de cardiologie, Hopiral Habib Thamteut, Tunis.

La Tunisie Medicale
|December 30, 2006
PubMed

Insights

Diabetes significantly worsens coronary artery disease (CAD) outcomes. Optimal management involves controlling blood sugar, lipids, and blood pressure, alongside proven drug therapies and revascularization strategies for better survival.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Medicine

Background:

  • Diabetes is an independent risk factor for coronary artery disease (CAD).
  • Diabetic patients with CAD have poorer survival rates compared to non-diabetic patients.
  • CAD in diabetes presents unique challenges, including more extensive atherosclerosis and frequent asymptomatic presentation.

Purpose of the Study:

  • To review the specific characteristics of coronary artery disease in diabetic patients.
  • To outline optimal therapeutic strategies for managing CAD in the context of diabetes.
  • To discuss the efficacy of various treatment modalities, including medical therapy and revascularization.

Main Methods:

  • Review of existing literature on diabetes and coronary artery disease.
  • Analysis of therapeutic strategies focusing on glycemic, lipid, and blood pressure control.
  • Evaluation of secondary prevention drug therapies and revascularization outcomes.

Main Results:

  • Diabetic CAD is characterized by extensive atherosclerosis and often asymptomatic disease.
  • Comprehensive management including blood glucose, lipid, and blood pressure control is crucial.
  • Diabetic patients benefit significantly from secondary prevention medications (aspirin, statins, beta-blockers, ACE inhibitors).
  • Both percutaneous coronary intervention and surgical myocardial revascularization are effective, with recent data favoring surgical approaches.
  • Drug-eluting stents show promise in reducing restenosis rates.

Conclusions:

  • Optimal management of diabetic CAD requires a multi-faceted approach addressing metabolic abnormalities and cardiovascular risk factors.
  • Aggressive secondary prevention with medication and appropriate revascularization strategies are vital for improving outcomes in diabetic patients with CAD.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...